Accordingly, our review results supported earlier suggestion of clinical usefulness of VEGF in the diagnosis of cervical cancer; subject to more robust clinical translation studies with larger consecutive cohorts of women participants. This evidence concerns the gene VEGFA and cervical carcinoma.